Eli Lilly and Company (NYSE:LLY) is included among 13 Best Long Term Low Risk Stocks to Buy Now. On February 5, Goldman Sachs ...
Realtor.com on MSN
Pennsylvania braces for homebuyer boom as weight-loss giant Eli Lilly announces $3.5 billion plant
Eli Lilly’s plant is set to inject 850 high-paying jobs into Pennsylvania's Lehigh Valley, potentially triggering home price ...
One of the assets shelved by Eli Lilly is a gene therapy for dementia, which it obtained in its $1.04-billion acquisition of ...
The market for obesity drugs may soon reach almost $100 billion.
The stock price has climbed in the triple digits over three years.
Eli Lilly and Company earnings beat lifts stock: revenue/EPS beat guidance, and the 2026 outlook looks strong, but watch ...
Lilly CEO Dave Ricks is confident in the ability of the company's pill to compete and is preparing for a "full launch" in the second quarter.
U.S. drugmaker Eli Lilly and Company signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the ...
As Eli Lilly awaits an FDA approval decision for its oral GLP-1 orforglipron, the pharma has discarded three clinical-stage ...
Novo Nordisk and Eli Lilly both think the Wegovy pill is doing well, but the American rival sees the successful launch as a harbinger of good news for its own candidate, orforglipron, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results